Studies examining the biological pathways used by tumors to sustain and augment their growth will further our understanding of cancer and identify novel therapeutic targets. Malignant gliomas represent 40 percent of primary brain tumors and have the highest mortality among CNS tumors, with death usually occurring in less than a year. Our long-range goal is to improve our comprehension of molecular and biological mechanisms leading to the malignant progression of human astrocytoma. The experiments proposed in this application will clarify the role of the IL-8, TSP-1 and BAI-1 angiogenesis modulators in astrocytoma progression using in vivo glioma models and will evaluate their importance as targets (IL-8) or tools (TSP-1, BAI-1) for therapy. The role of IL-8 as a growth/angiogenic stimulator and the biological basis of this activity will be functionally tested by three independent lines of research: i) overexpression of IL-8, ii) downmodulation of IL-8 and iii) antagonizing IL-8 receptor signalling. The relationship between IL-8 and VEGF will be investigated in an animal tumor model using a glioma cell line which contains a conditional VEGF gene knockout. The role of DARC and infiltrating inflammatory cells in mediating IL-8- induced angiogenesis will also be evaluated. The ability of TSP- 1 or its type 1 repeats to inhibit glioma growth/angiogenesis and the biological mechanism(s) underlying this effect will be examined by overexpression studies. In addition, the expression of TSP-1 in normal brain and during astrocytoma progression, in paired low grade/high grade tumors, will be analyzed. BAI-1 is a recently cloned brain specific inhibitor of angiogenesis which is downregulated in gliomas. The expression of BAI-1 will be examined in normal and tumoral brian using two anti-BAI-1 antibodies that were recently generated in our laboratory. In addition, the anti-angiogenic properties of BAI-1 and its ability to inhibit glioma growth will be also examined. Moreover, whether BAI-1 is the previously identified p53 regulated GD-AIF angiogenesis inhibitor will be determined. Finally, the therapeutic potential of combining these anti-angiogenic approaches will be tested and then subsequently conjugated with anti-VEGF or BCNU chemotherapy administration. Improving the treatment of malignant gliomas, an incurable disease, is an important human health goal.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA086335-02
Application #
6377905
Study Section
Special Emphasis Panel (ZCA1-SRRB-3 (J1))
Program Officer
Woodhouse, Elizabeth
Project Start
2000-04-01
Project End
2005-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
2
Fiscal Year
2001
Total Cost
$338,220
Indirect Cost
Name
Emory University
Department
Neurosurgery
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Zhu, Dan; Osuka, Satoru; Zhang, Zhaobin et al. (2018) BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation. Cancer Cell 33:1004-1016.e5
Bolyard, Chelsea; Meisen, W Hans; Banasavadi-Siddegowda, Yeshavanth et al. (2017) BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection-Implications for Oncolytic Viral Therapy. Clin Cancer Res 23:1809-1819
Kim, Yong Joon; Kaluz, Stefan; Mehta, Anil et al. (2017) Purifying Properly Folded Cysteine-rich, Zinc Finger Containing Recombinant Proteins for Structural Drug Targeting Studies: the CH1 Domain of p300 as a Case Example. Bio Protoc 7:
Aust, Gabriela; Zhu, Dan; Van Meir, Erwin G et al. (2016) Adhesion GPCRs in Tumorigenesis. Handb Exp Pharmacol 234:369-396
Kalinina, Juliya; Ahn, Jun; Devi, Narra S et al. (2016) Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase. Clin Cancer Res 22:6256-6265
Okura, Hidehiro; Golbourn, Brian J; Shahzad, Uswa et al. (2016) A role for activated Cdc42 in glioblastoma multiforme invasion. Oncotarget 7:56958-56975
Zhu, Dan; Li, Chenchen; Swanson, Andrew M et al. (2015) BAI1 regulates spatial learning and synaptic plasticity in the hippocampus. J Clin Invest 125:1497-508
Kim, Hoon; Zheng, Siyuan; Amini, Seyed S et al. (2015) Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution. Genome Res 25:316-27
Chen, Gang; Kong, Jun; Tucker-Burden, Carol et al. (2014) Human Brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma. Cancer Res 74:4536-48
Zerrouqi, Abdessamad; Pyrzynska, Beata; Brat, Daniel J et al. (2014) P14ARF suppresses tumor-induced thrombosis by regulating the tissue factor pathway. Cancer Res 74:1371-8

Showing the most recent 10 out of 78 publications